DOCSLIB.ORG

Stabilization Stabilizor Workflow Inactivation of Enzymes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stabilization Stabilizor Workflow Inactivation of Enzymes Denator Novel Tissue Sample Preparation Technology for MS Analysis denator.com WATERS 2nd NORDIC MS SYMPOSIUM Tuesday Nov 8 2011 Båstad Katarina Alenäs Denator 2004 University spin-off 2006 Head office at Biotech Center Gothenburg, Sweden Research lab in Uppsala Science Park, Sweden 2008 Stabilizor T1 – Launch 2009-to date Publications: Svensson et al. “Heat stabilization of the tissue proteome” Journal of Proteome Research, 2009 Robinson et al. “Assessing the use of thermal treatment to preserve the intact proteomes of post-mortem heart and brain tissue” Proteomics, 2009 Scholz et al. “Impact of temperature dependent sampling procedures in proteomics and peptidomics” Molecular and Cellular Proteomics, 2010 Goodwin et al. “Stopping the clock on proteomic degradation by heat-treatment at the point of tissue excision” Proteomics, 2010 Rountree et al “Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization” Proteome Science, 2010 Ahmed et al “Preserving protein profiles in tissue samples: Differing outcomes with and without heat stabilization” Journal of Neuroscience Methods, 2011 Colgrave et al “Neuropeptide profiling of the bovine hypothalamus: Thermal stabilization is an effective tool in inhibiting post-mortem degradation” Colgrave et al, Proteomics, 2011 Protein research workflow Collection Sample prep Analysis Bioinformatics Stabilization Extraction 2D-gels Dissection Clean up MS Storage Enrichment Western blot Transport Trypsin cleavage ELISA Laboratory for Biological and Medical Mass Spectrometry, Uppsala University, 2002 Schematic flowchart of the peptidomics experimental setup Brain dissection •Homogenization Peptide •Centrifugation extraction •10 kDa cut-off filtration •Concentration Nano LC •Desalting system •Separation •ESI-MS •mass information MS •relative intensity levels MS/MS •Collision induced dissociation •sequence information Data •Differential peptide display analysis •Identifications by database matching Microwave fixation system Focus MW energy Inactivate enzymes Prevent post-mortem changes Protein degradation - post sampling 0 min 10 min Svensson et al., Journal of Proteome Research 2009, 8(2), pp 974–981 Degradation Rapid increase of peptides -> the result of degradation “New” peptides were fragments from high abundant proteins min Sköld, et al., Proteomics 2007, 7(24), pp 4445 Peptide intensity post sampling Leu-Enk P OM C Leu-Enk POMC BetaBeta endorphin endor phin 140000 2500000 1200000 120000 2000000 1000000 100000 800000 1500000 80000 600000 60000 1000000 400000 40000 500000 200000 20000 0 0 0 0 1 3 10 01 12 33 104 01 12 33 104 0 1 3 10 min post-mortem min post-mortem min post-mortem The stability of neuropeptides post sampling Sköld, et al., Proteomics 2007, 7(24), pp 4445 The importance of sample handling Proteins, peptides and their modifications can change rapidly post sampling Standardization of sampling and rapid stabilization of molecules of interest is key for high quality protein studies Phosphorylated proteins are heavily involved in Signaling transduction and they change rapidly post sampling or during sample preparation if they are not stabilized Maintainor® Tissue Stabilizor® T1 Treatment/Storage Stabilization Stabilizor workflow Inactivation of enzymes Svensson et al., Journal of Proteome Research 2009, 8(2), pp 974–981 MD LCMS MALDI MS Imaging ELISA 2D gels RPPA Western blot Proteins and peptides - 2D-gels - MALDI MS Imaging -LCMS Proteomics – 2D-gels Collaboration with Professor Mike Dunn, UCD Conway, Ireland Sample handling is crucial Current workflow not satisfactory Mouse brain: Proteomics Stabilization results in: Locations of differentially expressed proteins 4 7 250 High molecular weight spots increase ) Low molecular weight spots kDa 3 decrease Identifications show less (x10 Wt. Mol. degradation in stabilized samples 16 ”Stabilization shows a favourable effect on the integrity of the mouse brain proteome affording increased abundance of several intact proteins and reduced fragmentation.” Robinson et al., Proteomics 2009, 19(9):4433-4444 Mouse brain: Peptidomics on MALDI-IMS Stabilized Untreated Mw 6723,5 Goodwin et al., Proteomics 2010, 10 (9):1751-61 Biomarkers of interest in xenografts FFPE Stabilized+FFPE Data courtesy of The Institute of Cancer Research, UK Peptidomics – Mass spectrometry Collaboration with professor Per Andrén at Uppsala University Mouse model of Parkinson Sample handling is crucial Nano-LC-ESI MS Somatostatin Proenkephalin A 198-209 Thymosin melanotropin α Leu-ENK Met-ENK-RSL Met-ENK-RF Thymosin Proenkephalin A 198-209 Somatostatin melanotropin α Met-ENK-RSL Leu-ENK Met-ENK-RF Untreated Stabilized Svensson et al., Journal of Proteome Research 2009, 8(2), pp 974–981 LTQ-Orbitrap MS Mouse brain peptidomics with LCMS x106 90000009 80000008 70000007 60000006 50000005 40000004 30000003 Intensity 20000002 10000001 Detected intensity Detected 0 Endorphin Nociceptin Cerebellin 4 Met-Enk-RSL CART 62-102 Stabilized Gastrin rel. Peptide Untreated In collaboration with Dr. Capdevielle, Sanofi-Aventis, France Phosphorylations - Western Blot - Mass spectrometry Phosphorylation levels in clinical samples – up or down regulation can distort the analysis Espina et al., Molecular and Cellular Proteomics 2008, 7, pp 1998-2018 Western blot Phosphorylated proteins D MW 1 3 10 4000,0 3500,0 3000,0 2500,0 Denator Denator+2h RT 2000,0 SF + 10 min 1500,0 1000,0 500,0 Comparison between focused 0,0 MW and Denator in combination with a time course study. Level of phosphorylated protein Level of phosphorylated Brain-GSK Brain-CREB Brain-MAPK Svensson et al., Journal of Proteome Research 2009, 8(2), pp 974–981 Nano-LC-ESI MS Phosphorylated peptides Phosphorylated peptides 8 7 6 5 4 3 2 Relative abundance Relative log^2 1 0 Untreated Fresh treated Frozen treated Secretogranin-1 derived phosphorylated peptides In collaboration with Karolinska Institutet Reversed Phase Protein Arrays Stabilization preserves PTM’s for 24hrs Stabilizor T1 Instrument Heat system • Optimized conductive heat • Homogenous and rapid Vacuum system • Fully automatic • Optimizes the heat transfer Treatment time assessment • Ensures total inactivation • Ensures reproducibility Tracking system Info Size: 465 x 306 x 143 mm (l x w x h) Weight: 6,7 Kg Requirements: 110/220 volt Maintainor Tissue • For treatment and storage • Facilitates rapid and effective sample collection • Ensures effective heat transfer during treatment • Provides optimal conditions for transport and long-term storage Info Volume: 33 x 7 mm Stabilization Size: 85 x 54 x 2 mm Material : FEP (inert) Operating temp: -80 to 100 C CONFIDENTIAL Points of use Animal facility Stabilization of fresh tissue samples Operation room Stabilization of biopsies Stabilization of tissue from operations Lab Stabilization of frozen tissue samples Easy to use • Auto calibration • Pre-programmed methods • Portable Application support [email protected] +46 18 50 81 00 Some Stabilizor T1 publications “Assessing the use of thermal treatment to preserve the intact proteomes of post-mortem heart and brain tissue” Aisling A. Robinson, Jules A. Westbrook , Jane A. English , Mats Borén , Michael J. Dunn, Proteomics, 2009, 19 (9), pp 4433-4444 “Heat stabilization of the Tissue Proteome: A New Technology for Improved Proteomics” Marcus Svensson, Mats Borén, Karl Sköld, Maria Fälth, Benita Sjögren, Malin Andersson, Per Svenningsson, Per E. Andrén, Journal of Proteome Research, 2009, 8 (2), pp 974–981 “Impact of temperature dependent sampling procedures in proteomics and peptidomics-A characterization of the liver and pancreas post mortem degradome” Birger Scholz, Karl Sköld...Roman Zubarev, Peter James, Molecular and Cellular Proteomics, accepted Pre-print 27 Jan 2010 “Stopping the clock on proteomic degradation by heat-treatment at the point of tissue excision” Richard J.A. Goodwin, Alastair M. Lang…Andrew R. Pitt, Proteomics, 2010, 10 (9), pp 1751-61 “Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization” C Bart Rountree, Colleen V Kirk..Willard M Freeman, Proteome Sci. 2010; 8: 61 “Preserving protein profiles in tissue samples: Differing outcomes with and without heat stabilization” Md. Mahiuddin Ahmed and Katheleen J. Gardiner, Journal of Neuroscience Methods, article in press January 2011 “Neuropeptide profiling of the bovine hypothalamus: Thermal stabilization is an effective tool in inhibiting post-mortem degradation” Colgrave et al, Proteomics 2011, 11, 1–13 “Benefits of heat-treatment to the protease packed neutrophil for proteome analysis: Halting protein degradation” Kennedy et al, Proteomics 2011, 11 (10) published online Apr 8 "Thermal Stabilization of Tissues and the Preservation of Protein Phosphorylation States for Two-Dimensional Gel Electrophoresis” Smejkal et al, Electrophoresis 2011 published on line April 2011 Some Stabilizor T1 users worldwide CSRIO, Livestock Industries, Australia Universidade de Vigo, Spain Capital Medical University Beijing, China Uppsala University, Sweden Copenhagen University, Denmark Karolinska Institutet, Sweden NovoNordisk, Denmark Leiden Medical University Center, Netherlands Helsinki University, Finland Delft University of Technology, Netherlands Turku Biotechnology Center, Finland St.George’s Biomics Center London, UK Max-Planck-Institute, Germany MerckSharpDome, USA University College Dublin, Ireland Penn State University, USA Tokohuso University Hospital, Japan University of Colorado, USA University of Fribourg, Switzerland University of Pennsylvania, USA Summary Protein degradation is rapid and may cause problems downstream Standardization within sample collection is important Rapid and homogenous heat inactivation is an efficient technique to keep the sample as close to its in-vivo state as possible Acknowledgements Professor Michael J. Dunn, Conway Institute of Biomolecular & Biomedical Research, Ireland Professor Per Andrén, BMMS, Uppsala University, Sweden Professor Andrew Pitt, Dept. of Integrative and Systems Biology, Glasgow University, UK Dr Per Svenninsson, Dept. of Physiology and Pharmacology, Karolinska Institutet, Sweden Dr Joel Capdevielle, Sanofi-Aventis, France denator.com www.denator.com.
Load more

Recommended publications
  • Joy Wellness Partners 838 W G Street Suite 201 San Diego, California 92101
    United States of America FEDERAL TRADE COMMISSION Southwest Region 1999 Bryan St., Ste. 2150 Dallas, Texas 75201 June 3, 2020 WARNING LETTER VIA EMAIL TO [email protected] Joy Wellness Partners 838 W G Street Suite 201 San Diego, California 92101 Re: Unsubstantiated Claims for Coronavirus Prevention or Treatment To Whom It May Concern, This is to advise you that FTC staff reviewed your website at https://joywellnesspartners.com/ on May 24, 2020. We have determined that you are unlawfully advertising that certain products treat or prevent Coronavirus Disease 2019 (COVID-19). Some examples of Coronavirus treatment or prevention claims on your website include: In marketing materials accessible on your website by selecting “BLOG” from the navigation menu and clicking on “CORONAVIRUS (COVID-19),” you claim: o Under the heading “Hormones, Peptides, & Immunity”: . You state that “Keeping your immune system running optimally with balanced hormones and peptides helps your body prevent and fight illness, including viruses like COVID-19. Book now [https://intakeq.com/booking/8hkwjk]” . You post a video titled “IMMUNITY, BIOTE, & CORONAVIRUS” featuring Carol Joy Bender, NP. In the video at approximately 31:55, Bender states, “More specifically, I wanted to touch on the things that we’re all concerned about the coronavirus times: what can I do to boost my immune system to keep me healthy? BioTE has already been doing this for us… We have a lot of patients that are already taking their iodine with selenium and zinc. The zinc is one of the mainstay treatments that many of you have read about… zinc helps to reduce the RNA replication inside the cells, when the coronavirus gets in.
    [Show full text]
  • Endogenous Peptide Discovery of the Rat Circadian Clock a FOCUSED STUDY of the SUPRACHIASMATIC NUCLEUS by ULTRAHIGH PERFORMANCE TANDEM MASS □ SPECTROMETRY* S
    Research Endogenous Peptide Discovery of the Rat Circadian Clock A FOCUSED STUDY OF THE SUPRACHIASMATIC NUCLEUS BY ULTRAHIGH PERFORMANCE TANDEM MASS □ SPECTROMETRY* S Ji Eun Lee‡§, Norman Atkins, Jr.¶, Nathan G. Hatcherʈ, Leonid Zamdborg‡§, Martha U. Gillette§¶**, Jonathan V. Sweedler‡§¶ʈ, and Neil L. Kelleher‡§‡‡ Understanding how a small brain region, the suprachias- pyroglutamylation, or acetylation. These aspects of peptide matic nucleus (SCN), can synchronize the body’s circa- synthesis impact the properties of neuropeptides, further ex- dian rhythms is an ongoing research area. This important panding their diverse physiological implications. Therefore, time-keeping system requires a complex suite of peptide unveiling new peptides and unreported peptide properties is hormones and transmitters that remain incompletely critical to advancing our understanding of nervous system characterized. Here, capillary liquid chromatography and function. FTMS have been coupled with tailored software for the Historically, the analysis of neuropeptides was performed analysis of endogenous peptides present in the SCN of the rat brain. After ex vivo processing of brain slices, by Edman degradation in which the N-terminal amino acid is peptide extraction, identification, and characterization sequentially removed. However, analysis by this method is from tandem FTMS data with <5-ppm mass accuracy slow and does not allow for sequencing of the peptides con- produced a hyperconfident list of 102 endogenous pep- taining N-terminal PTMs (5). Immunological techniques, such tides, including 33 previously unidentified peptides, and as radioimmunoassay and immunohistochemistry, are used 12 peptides that were post-translationally modified with for measuring relative peptide levels and spatial localization, amidation, phosphorylation, pyroglutamylation, or acety- but these methods only detect peptide sequences with known lation.
    [Show full text]
  • Thymosin Hh10 Inhibits Angiogenesis and Tumor Growth by Interfering with Ras Function
    Research Article Thymosin hh10 Inhibits Angiogenesis and Tumor Growth by Interfering with Ras Function Seung-Hoon Lee,1 Myung Jin Son,1,2 Sun-Hee Oh,1 Seung-Bae Rho,1 Kyungsook Park,1 Yung-Jin Kim,2 Mi-Sun Park,1 and Je-Ho Lee1 1Molecular Therapy Research Center, Samsung Medical Center, School of Medicine, Sung Kyun Kwan University, Seoul, Korea and 2Department of Molecular Biology, Pusan National University, Busan, Korea Abstract are a family of highly conserved small peptides that inhibit barbed end actin polymerization by sequestering actin mono- Thymosin h10 is a monomeric actin sequestering protein mers (8). Among them, thymosin h4 and thymosin h10 are the that regulates actin dynamics. Previously, we and others h have shown that thymosin h acts as an actin-mediated two most abundant -thymosins in the mammalian species and 10 coexist in some tissue types at varying ratios (9). Although both tumor suppressor. In this study, we show that thymosin h10 is not only a cytoskeletal regulator, but that it also acts as a peptides share a high degree of sequence homology, they show potent inhibitor of angiogenesis and tumor growth by its distinct patterns of expression in several tissues (10) and play interaction with Ras. We found that overexpressed thymosin different roles during rodent development (11). Recently, the angiogenic effects of several members of the thymosin family of h10 significantly inhibited vascular endothelial growth factor–induced endothelial cell proliferation, migration, peptides were studied in the chick chorioallantoic membrane h a invasion, and tube formation in vitro. Vessel sprouting was model (12).
    [Show full text]
  • Multiple Beneficial Effects of Melanocortin MC4 Receptor
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Archivio della ricerca - Università degli studi di Napoli Federico II Progress in Neurobiology 148 (2017) 40–56 Contents lists available at ScienceDirect Progress in Neurobiology journal homepage: www.elsevier.com/locate/pneurobio Review article Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives a a a b c Daniela Giuliani , Alessandra Ottani , Laura Neri , Davide Zaffe , Paolo Grieco , d e f a, Jerzy Jochem , Gian Maria Cavallini , Anna Catania , Salvatore Guarini * a Department of Biomedical, Metabolic and Neural Sciences, Section of Pharmacology and Molecular Medicine, University of Modena and Reggio Emilia, Modena, Italy b Department of Biomedical, Metabolic and Neural Sciences, Section of Human Morphology, University of Modena and Reggio Emilia, Modena, Italy c Department of Pharmacy, University of Napoli “Federico II”, Napoli, Italy d Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland e Department of Ophthalmology, University of Modena and Reggio Emilia, Modena, Italy f Center for Preclinical Surgical Research, Fondazione IRCCS Ca' Granda À Ospedale Maggiore Policlinico, Milano, Italy A R T I C L E I N F O A B S T R A C T Article history: Received 20 May 2015 Melanocortin peptides induce neuroprotection in acute and chronic experimental neurodegenerative Received in revised form 22 November 2016 conditions. Melanocortins likewise counteract systemic responses to brain injuries. Furthermore, they Accepted 28 November 2016 promote neurogenesis by activating critical signaling pathways. Melanocortin-induced long-lasting Available online 1 December 2016 improvement in synaptic activity and neurological performance, including learning and memory, sensory-motor orientation and coordinated limb use, has been consistently observed in experimental Keywords: models of acute and chronic neurodegeneration.
    [Show full text]
  • Supporting Information for Proteomics DOI 10.1002/Pmic.200700142
    Supporting Information for Proteomics DOI 10.1002/pmic.200700142 Karl Skld, Marcus Svensson, Mathias Norrman, Benita Sjgren, Per Svenningsson and Per E. Andren´ The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: Stathmin 2-20 and peptides as sample quality indicators ª 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com SUPPORTING INFORMATION Supporting Information Table 1. Degraded protein identities and peptide sequences in the striatum after 1, 3, and 10 min post-mortem. UniProtKBa. Protein name Sequenceb Scorec P60710/P63260 Actin, cytoplasmic 1,2 A.LVVDNGSGMCK.A 56 E.MATAASSSSLEKS.Y 55 W.IGGSILASLSTFQQ.M 64 W.ISKQEYDESGPSIVHRK.C 93 M.WISKQEYDESGPSIVHRK.C 56 Q8K021 Secretory carrier-associated F.ATGVMSNKTVQTAAANAASTAATSAAQNAFKGNQM.- 124 membrane protein 1 Q9D164 FXYD domain-containing ion L.ITTNAAEPQK.A 58 transport regulator 6 precursor L.ITTNAAEPQKA.E 57 L.ITTNAAEPQKAE.N 89 L.ITTNAAEPQKAEN.- 54 P99029 Peroxiredoxin 5, mitochondrial M.APIKVGDAIPSVEVF.E 57 precursor P01942 Hemoglobin alpha subunit F.LASVSTVLTSKYR.- 106 M.FASFPTTKTYFPHF.D 72 L.ASHHPADFTPAVHASLDK.F 76 T.LASHHPADFTPAVHASLDK.F 59 L.LVTLASHHPADFTPAVHAS.L 56 L.LVTLASHHPADFTPAVHASLDK.F 71 L.LVTLASHHPADFTPAVHASLDKFLASVST.V 66 T.LASHHPADFTPAVHASLDKFLAS.V 55 L.VTLASHHPADFTPAVHASLDKFLAS.V 68 -.VLSGEDKSNIKAAWGKIGGHGAEYGAEALER.M 97 -.VLSGEDKSNIKAAWGKIGGHGAEYGAEALERM.F 58 P02088/P02089 Hemoglobin beta-1,2 subunit L.LVVYPWTQRY.F 53 L.LVVYPWTQRYF.D 52 Q00623 Apolipoprotein A-I precursor Y.VDAVKDSGRDYVSQFESSSLGQQLN.L
    [Show full text]
  • Information to Users
    INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality 6" x 9" black and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. A Bell & Howell Information Company 300 North Zeeb Road. Ann Arbor. Ml 48106-1346 USA 313/761-4700 800/521-0600 Order Number 9517090 Partial characterization and purification of steroidogenic factors in thymic epithelial cell culture-conditioned medium Uzumcu, Mehmet, Ph.D. The Ohio State University, 1994 UMI 300 N.
    [Show full text]
  • Mass Spectrometry-Based Discovery of Circadian Peptides
    Mass spectrometry-based discovery of circadian peptides Nathan G. Hatcher*†, Norman Atkins, Jr.‡, Suresh P. Annangudi*†, Andrew J. Forbes*, Neil L. Kelleher*§, Martha U. Gillette‡§¶, and Jonathan V. Sweedler*†‡§ ʈ *Department of Chemistry; †Beckman Institute; ‡Neuroscience Program; ¶Department of Cell and Developmental Biology; and §Institute for Genomic Biology, University of Illinois, Urbana, IL 61801 Communicated by William T. Greenough, University of Illinois at Urbana–Champaign, Urbana, IL, May 20, 2008 (received for review January 18, 2008) A significant challenge to understanding dynamic and heteroge- (5–8). Captured releasates then were characterized offline with neous brain systems lies in the chemical complexity of secreted MALDI TOF MS. Following this strategy, releasates could be intercellular messengers that change rapidly with space and time. screened for multiple compounds that include known, unex- Two solid-phase extraction collection strategies are presented that pected, or even unknown compounds. relate time and location of peptide release with mass spectrometric We characterized peptides endogenously secreted from the characterization. Here, complex suites of peptide-based cell-to-cell site of the SCN over the course of 24 h as well as peptides signaling molecules are characterized from the mammalian supra- released specifically following electrophysiological stimulation chiasmatic nucleus (SCN), site of the master circadian clock. Ob- of the retinohypothalamic (RHT) tract, the afferent pathway served SCN releasates are peptide rich and demonstrate the co- mediating SCN phase-setting light cues (9, 10). Surprisingly release of established circadian neuropeptides and peptides with complex SCN neuropeptide release spectra were observed with unknown roles in circadian rhythms. Additionally, the content of the use of a combination of neurophysiology and selective SCN releasate is stimulation specific.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,133,863 B2 Maggio (45) Date of Patent: Mar
    USOO8133863B2 (12) United States Patent (10) Patent No.: US 8,133,863 B2 Maggio (45) Date of Patent: Mar. 13, 2012 (54) STABILIZING ALKYLGLYCOSIDE 3.5. A g E. S. et al COMPOSITIONS AND METHODS THEREOF 5,369,095 A 1 1/1994 KeeOnahoe et al. et al. 5,556,757 A 9, 1996 A1 tal. (75) Inventor: Edward T. Maggio, San Diego, CA 5,556,940 A 9, 1996 WRC (US) 6,524,557 B1 2/2003 Backstrom et al. 6,551.578 B2 * 4/2003 Adjei et al. ..................... 424/45 (73) Assignee: Aegis Therapeutics, LLC, San Diego, 2002fO1105247,425,542 A1B2 9/20088, 2002 CowanMaggio et al. CA (US) 2004/0209814 A1 10, 2004 Nauck et al. 2005/0215475 A1 9/2005 Ong et al. (*) Notice: Subject to any disclaimer, the term of this 2005/0276843 Al 12/2005 Quay et al. patent is extended or adjusted under 35 2006/0046962 A1 3/2006 Meezan et al. .................. 514/12 2006, OO74025 A1 4/2006 Quay et al. U.S.C. 154(b) by 443 days. 2006/0183674 A1 8/2006 Brand et al. 21) Appl. No.: 12/360,758 2007/01 11938 A1 5, 2007 Pert et al. (21) Appl. No.: 9 (Continued) (22) Filed: Jan. 27, 2009 FOREIGN PATENT DOCUMENTS US 2009/0197816A1 Aug. 6, 2009 (Continued) OTHER PUBLICATIONS Related U.S. Application Data Brown et al. Affinity Purification of a Somatostatin Receptor-G- (60) Division of application No. 12/119,378, filed on May protein Complex... The Journal of Biological Chemistry. Mar. 25. 12, 2008, which is a continuation-in-part of 1993, Vol.
    [Show full text]
  • Slow” NGF Binding, Efficient NGF Uptake, and Multiple NGF Responses to NGF-Nonresponsive PC12 Cell Mutants
    The Journal of Neuroscience, July 1993, 13(7): 2919-2929 Transfection with frk Restores “Slow” NGF Binding, Efficient NGF Uptake, and Multiple NGF Responses to NGF-nonresponsive PC12 Cell Mutants David M. Loeb and Lloyd A. Greene Department of Pathology and Center for Neurobiology and Behavior, Columbia University, New York, New York 10032 NGF binds to and activates the protein tyrosine kinase line PC 12 (Greene and Tischler, 1976) has been used extensively gp140prototrk. Expression of this receptor is required for at as an in vitro model to study NGF signaling (Levi et al., 1988). least some responses to NGF. Three outstanding issues are Two distinct NGF receptors, designated ~75 and gp140proto1rk addressed in the present work. First, we determined whether (Trk), have been identified, and cDNAs encoding these have expression of gpl40 protot* is required for all neuronal NGF been cloned (Chao et al., 1986; Radeke et al., 1987; Martin- responses. Second, we examined the role of gp140Pmtot* in Zanca et al., 1989). The discovery that NGF binds to and stim- NGF binding and internalization. Third, we addressed the ulates the tyrosine kinase activity of the gp140~~~‘~‘~~(Bothwell, utility of NGF-nonresponsive PC1 2nnr5 cells for study of the 199 1; Kaplan et al., 199 la,b; Klein et al., 1991) has focused NGF mechanism. In contrast to wild-type PC12 cells, attention on its role in NGF signal transduction. Transfection PC1 2nnr5 cells do not express endogenous gpl40~~~‘~‘*. We experiments have demonstrated that gp140~~~‘~“~mediates NGF- therefore asked whether they possess other defects that stimulated fibroblast transformation (Cordon-Card0 et al., 199 1) compromise NGF signaling pathways.
    [Show full text]
  • Interaction of Dietary Fat and the Thymus in the Induction of Mammary Tumors by 7,12-Dimethylbenz(A)Anthracene1
    [CANCER RESEARCH 42. 1266-1273, April 1982] 0008-5472/82/0042-OOOOS02.00 Interaction of Dietary Fat and the Thymus in the Induction of Mammary Tumors by 7,12-Dimethylbenz(a)anthracene1 David A. Wagner,2 Paul H. Naylor,3 Untae Kim, Wendy Shea, Clement Ip, and Margot M. Ip4 Department of Experimental Therapeutics, Grace Cancer Drug Center [D. A. W., P. H. N., W. S., M. M. I.], and Departments of Pathology [U. KJ and Breast Surgery [C. I.], New York State Department of Health, Roswe/l Park Memorial Institute, Buffalo, New York 14263 ABSTRACT the host, specifically an elevation of serum prolactin levels, might be responsible for this effect (11, 34). Other possibilities The interaction of dietary fat and the thymus in the induction include an effect of dietary fat on the immune system (20, 22, of mammary tumors by dimethylbenz(a)anthracene has been 43), prostaglandins (30), or through maintenance and induction examined in female Sprague-Dawley rats. In these experi of prolactin receptors (42). ments, rats fed diets of 0.5% (low fat), 5% (normal fat), or 20% There is some experimental evidence which indicates that (high fat) corn oil from weaning (21 days of age) were thymec- the thymus can modulate mammary tumorigenesis. For exam tomized or sham thymectomized at 35 days of age and were ple, neonatal thymectomy has been shown to decrease the given 5 mg of dimethylbenz(a)anthracene at 55 days of age. incidence and increase the latency period of spontaneous (58), Thymectomy exerted a protective effect in rats fed low and transplantable (3), and chemical- or virus-induced mammary normal fat diets, and this was not reversed by Thymosin Frac tumors (28, 44, 45, 53, 55, 56, 60, 66).
    [Show full text]
  • (Fx Peptide) Is a Potent Regulator of Actin Polymerization in Living Cells (Cytoskeleton/Assembbly) MITCHELL C
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 4678-4682, May 1992 Cell Biology Thymosin 134 (Fx peptide) is a potent regulator of actin polymerization in living cells (cytoskeleton/assembbly) MITCHELL C. SANDERS*, ALLAN L. GOLDSTEINt, AND Yu-Li WANG*t *Cell Biology Group, Worcester Foundation for Experimental Biology, 222 Maple Avenue, Shrewsbury, MA 01545; and tDepartment of Biochemistry and Molecular Biology, The George Washington University School of Medicine and Health Services, Washington, DC 20037 Communicated by Paul C. Zamecnik, February 3, 1992 ABSTRACT Thymosin .84 (f84) is a 5-Ala polypeptide bind a significant portion of monomeric actin and inhibit originally identified in calf thymus. Although numerous activ- salt-induced polymerization of actin filaments in vitro (22, ities have been attributed to .34, its physiological role remains 23). Since (4 appears to be present at a higher level than most elusive. Recently, (34 was found to bind actin in human platelet other actin sequestration factors in platelets and cultured extracts and to inhibit actin polymerization in vitro, raising the cells (20-23), it is possible that (4 may represent the primary possibility that it may be a physiological regulator of actin factor responsible for the regulation of actin polymerization assembly. To eamine this potential function, we have in- (24). creased the cellular A concentration by mlcroilJecting syn- One approach to test this putative physiological role of(4 thetic (34 into living epitheial cells and fibroblasts. The injec- is to induce the "overexpression" in living cells and to tion induced a diminution ofstress fibers and a dose-dependent examine the subsequent effects on specific structures or depolymerization ofactin filaments as indicated by quantitative functions.
    [Show full text]
  • Increasing Heart Vascularisation After Myocardial Infarction Using Brain Natriuretic Peptide Stimulation of Endothelial and WT1+ Epicardium- Derived Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.17.207985; this version posted July 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Increasing heart vascularisation after myocardial infarction using brain natriuretic peptide stimulation of endothelial and WT1+ epicardium- derived cells. Na Li, Stéphanie Rignault-Clerc, Christelle Bielmann, Anne-Charlotte Bon-Mathier, Tamara Déglise, Alexia Carboni, Mégane Ducrest, Nathalie Rosenblatt-Velin* Division of Angiology, Heart and Vessel Department, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland. Short Title: BNP improves heart neovascularisation Address for correspondance: * Nathalie Rosenblatt-Velin, PhD CHUV, Division d’Angiologie Département Cœur-Vaisseaux Institut de Physiologie, Bugnon 7a, 1005 Lausanne, Switzerland Phone: +41 79 556 76 68 Fax: +41 21 692 55 95 Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.07.17.207985; this version posted July 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 ABSTRACT Brain natriuretic peptide (BNP) treatment increases heart function and decreases heart dilation after myocardial infarction. Here, we investigated whether part of the cardioprotective effect of BNP in infarcted hearts related to improved neovascularisation. Infarcted mice were treated with saline or BNP for 10 days. BNP treatment increased vascularisation and the number of endothelial cells in the infarct border and remote zones of infarcted hearts. Endothelial cell lineage tracing showed that BNP directly stimulated the proliferation of resident mature endothelial cells in both areas of the infarcted hearts, via NPR-A binding and p38 MAP kinase activation.
    [Show full text]